Search Results for:
“Explainable” AI cracks secret language of sticky proteins
The new AI is able to predict when and why protein aggregation occurs, a mechanism linked to Alzheimer’s and 50 other diseases that affect 500 million people. The results show great potential for research into neurodegenerative diseases and for improving drug production, reducing costs and increasing efficiency. The study, published today in Science Avances, is the result of a collaboration between the Centre for Genomic Regulation (CRG) and the Institute of Bioengineering of Catalonia (IBEC).
Predoctoral researcher at the Nanoprobes and Nanoswitches Research Group
Ref: PhD-PG // Deadline: 12/05/2025
4ª Jornada Anual del GIPS
El IBEC es el coorganizador de la Jornada Anual de este año, que se celebrará el próximo 17 de junio y lleva como título ‘Investigación traslacional en tecnología y salud’. La … Read more
Bioengineering in the Territory
The Bioengineering in the Territory project aims to decentralize scientific knowledge and promote scientific education in an equitable way across the region. We want to ensure that everyone, regardless of … Read more
IBEC and UB lead the organisation of the AFM BioMed 2025 international congress in Barcelona
The Atomic Force Microscopy in Life Sciences and Nanomedicine (AFM BioMed) conference took place in Barcelona last week. The 2025 edition, which brought together 160 participants, was organised by the … Read more
PhD candidate at the Research Group Molecular Imaging for Precision Medicine in Barcelona
Ref: PhD- IM // Deadline: 25/04/2025
New advances in the fight against the most common form of lung cancer
A study led by the University of Barcelona in collaboraiton with the Institute for Bioengineering of Catalonia reveals that the functional assay dynamic BH3 profiling (DBP) can predict whether specific treatments will be effective in non-small cell lung cancer patients. The technique helps determine which therapy will be most effective by testing it directly on living cells, improving personalised therapies.
IBEC researcher Irene Marco-Rius receives Anatole Abragam Prize for her contributions to the field of magnetic resonance
Dr Irene Marco-Rius, principal investigator at the Institute for Bioengineering of Catalonia (IBEC), has been awarded the 2025 Anatole Abragam Prize for her pioneering work on the use of magnetic resonance to study cells grown on chips, allowing ex vivo metabolic assessment of disease mechanisms and therapy responses in controlled microenvironments. The award was presented at the Joint ENC-ISMAR Conference in California.
IBEC science reaches thousands at the 43rd Comic Barcelona
The Institute for Bioengineering of Catalonia (IBEC) was a major presence at the 43rd Comic Barcelona last week. Through an exhibition on everyday science, talks and informative workshops, IBEC was able to bring its cutting-edge research to an audience of all ages.